Milborne Healthcare Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 09035441

MILBORNE HEALTHCARE LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

31 May 2025

MILBORNE HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION

31 May 2025

	2025		2024
Note	£	£	£	£

FIXED ASSETS

Tangible assets	6		66,363		79,095

CURRENT ASSETS

Debtors	7	5,302	2,827
Cash at bank and in hand		161,191	173,078
		---------	---------
		166,493	175,905

CREDITORS: amounts falling due within one year	8	37,085		35,441
		---------		---------
NET CURRENT ASSETS			129,408		140,464
			---------		---------
TOTAL ASSETS LESS CURRENT LIABILITIES			195,771		219,559

PROVISIONS	12,945	15,332
	---------	---------
NET ASSETS	182,826	204,227
	---------	---------

CAPITAL AND RESERVES

Called up share capital	100	100
Profit and loss account	182,726	204,127
	---------	---------
SHAREHOLDERS FUNDS	182,826	204,227
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

MILBORNE HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 May 2025

These financial statements were approved by the board of directors and authorised for issue on 5 December 2025 , and are signed on behalf of the board by:

J R Milborne

Director

Company registration number: 09035441

MILBORNE HEALTHCARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 MAY 2025

1. GENERAL INFORMATION

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Melton House, 42 West Street, Oundle, Peterborough, PE8 4EF, United Kingdom.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. ACCOUNTING POLICIES

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	20% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold improvements	-	20% straight line
Plant & Machinery	-	15% reducing balance and 33 1/3% straight line
Motor Vehicles	-	25% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs.The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

Financial instruments

Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit and loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit and loss.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

4. EMPLOYEE NUMBERS

The average number of persons employed by the company during the year amounted to 3 (2024: 3 ).

5. INTANGIBLE ASSETS

	Goodwill
	£
Cost
At 1 June 2024 and 31 May 2025	240,000
	---------
Amortisation
At 1 June 2024 and 31 May 2025	240,000
	---------
Carrying amount
At 31 May 2025	–
	---------
At 31 May 2024	–
	---------

6. TANGIBLE ASSETS

	Leasehold improvements	Plant and machinery	Motor vehicles	Total
	£	£	£	£
Cost
At 1 June 2024	95,178	61,003	32,000	188,181
Additions	–	1,006	–	1,006
	--------	--------	--------	---------
At 31 May 2025	95,178	62,009	32,000	189,187
	--------	--------	--------	---------
Depreciation
At 1 June 2024	39,413	43,368	26,305	109,086
Charge for the year	9,518	2,796	1,424	13,738
	--------	--------	--------	---------
At 31 May 2025	48,931	46,164	27,729	122,824
	--------	--------	--------	---------
Carrying amount
At 31 May 2025	46,247	15,845	4,271	66,363
	--------	--------	--------	---------
At 31 May 2024	55,765	17,635	5,695	79,095
	--------	--------	--------	---------

7. DEBTORS

	2025	2024
	£	£
Trade debtors	3,156	2,827
Other debtors	2,146	–
	-------	-------
	5,302	2,827
	-------	-------

8. CREDITORS: amounts falling due within one year

	2025	2024
	£	£
Corporation tax	–	2,438
Other creditors	37,085	33,003
	--------	--------
	37,085	35,441
	--------	--------

9. OPERATING LEASES

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£
Not later than 1 year	24,000	24,000
Later than 1 year and not later than 5 years	–	24,000
	--------	--------
	24,000	48,000
	--------	--------

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year the directors entered into the following advances and credits with the company:

	2025
	Balance brought forward	Advances/ (credits) to the directors	Amounts repaid	Balance outstanding
	£	£	£	£
J Milborne	( 2,603)	3,319	( 650)	66
	-------	-------	----	----

	2024
	Balance brought forward	Advances/ (credits) to the directors	Amounts repaid	Balance outstanding
	£	£	£	£
J Milborne	–	–	–	–
	----	----	----	----

The loans were repaid within 9 months of the year end.